BioRestorative Therapies (BRTX) Gross Margin (2012 - 2025)
BioRestorative Therapies' (BRTX) quarterly Gross Margin came in at 91.65% in Q4 2025, down 64.0% YoY from 254.59% in Q4 2024, and up 779.27% on a QoQ basis from 10.42% in Q3 2025.
BioRestorative Therapies (BRTX) Gross Margin (2012 - 2025) Analysis & Trends
BioRestorative Therapies (BRTX) has 9 years of Gross Margin data on file, last reported at 91.65% in Q4 2025.
- Quarterly Gross Margin fell 64.0% year-over-year to 91.65% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 93.37% (up 37.0% YoY) and the FY2025 annual result came in at 93.37%, up 37.0% from the prior year.
- Gross Margin grew to 91.65% in Q4 2025, from 10.42% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2023 to a low of 10.42% in Q3 2025.
- A 3-year average of 87.71% and a median of 92.72% in 2024 frame the typical range for Gross Margin.
- The widest YoY moves for Gross Margin: up 441 bps in 2025, down 8177 bps in 2025.
- Tracing BRTX's Gross Margin over 3 years: stood at 100.0% in 2023, then declined by 8 bps to 92.29% in 2024, then declined by 1 bps to 91.65% in 2025.
- The last three Gross Margin figures came in at 91.65% (Q4 2025), 10.42% (Q3 2025), and 97.12% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | 85.33% |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 91.59% |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 90.43% |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | 35.86% |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | 89.76% |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | 76.90% |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | 63.27% |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | 84.20% |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | - |
| 10 | BioRestorative Therapies | 1.99 Mn | -960,047.75 | 17,964.00 | 91.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 91.65% |
| Sep 30, 2025 | 10.42% |
| Jun 30, 2025 | 97.12% |
| Mar 31, 2025 | 88.36% |
| Dec 31, 2024 | 92.29% |
| Sep 30, 2024 | 92.19% |
| Jun 30, 2024 | 92.72% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 100.00% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | 100.00% |
| Sep 30, 2017 | 100.00% |
| Jun 30, 2017 | 100.00% |
| Mar 31, 2017 | 100.00% |
| Dec 31, 2016 | 99.65% |
| Sep 30, 2016 | 100.00% |
| Jun 30, 2016 | 99.56% |
| Mar 31, 2016 | 99.89% |
| Dec 31, 2015 | 70.12% |
| Sep 30, 2015 | 47.02% |